Skip to main content
Rindert Missiaen on Muck Rack

Rindert Missiaen

As seen in: Cell Metabolism, Molecular Cancer Research
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Rindert

Contact Rindert, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

GCN2 inhibition sensitizes arginine-deprived hepatocellular carcinoma cells to senolytic treatment

|
By Rindert Missiaen, Nicole Anderson, Laura Kim, Bailey Nance
| Cell Metabolism Verified
Abou-Alfa G.K. Qin S. Ryoo B.Y. Lu S.N. Yen C.J. Feng Y.H. Lim H.Y. Izzo F. Colombo M. Sarker D. et al. Phase III randomized study of second line ADI-PEG 20 plus best supportive care versus placebo plus best supportive care in patients with advanced hepatocellular carcinoma. Ann. Oncol. 2018; 29: 1402-1408 Agrawal V. Alpini S.E. Stone E.M. Frenkel E.P. Frankel A.E. Targeting methionine auxotrophy in cancer: discovery & exploration. Expert Opin. Biol. Ther. 2012; 12: 53-61 Anda S. Zach R. Grallert B.
Open in Who Shared Issue with article?

Cell-Intrinsic Tumorigenic Functions of PPARγ in Bladder Urothelial Carcinoma

|
By Danielle Sanchez, Nicolas Skuli, David J. Steger, Rindert Missiaen
| Molecular Cancer Research Verified
Cancer Genes and Networks Danielle J. Sanchez, Rindert Missiaen, Nicolas Skuli, David J. Steger and M. Celeste Simon DOI: 10.1158/1541-7786.MCR-20-0189 Published April 2021 This article requires a subscription to view the full text. You may purchase access to this article or login to access your subscription using the links below.
Open in Who Shared Issue with article?
See all 2 articles